Notably, higher CD45 expression was positively correlated with a poorer TRG suggesting therapeutic resistance (Figure 2A); however, CD45 expression in cancer epithelial cells was not associated with post-therapeutic tumor stage (yStage), depth of tumor invasion (ypT) or lymph node metastasis (ypN). The gene discussed is PTPRC; the disease is cancer.